MARCELLE BOTHA: Open Payments
NPI 1790345536 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 21 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| ABIOMED | 4 | $83 |
| PFIZER INC. | 2 | $34 |
| Stryker Corporation | 1 | $28 |
| SCPHARMACEUTICALS INC. | 1 | $21 |
| Abbott Laboratories | 1 | $21 |
| Solventum Corporation | 1 | $18 |
| GENZYME CORPORATION | 1 | $17 |
| CORDIS US CORP. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: CAMZYOS, VYNDAQEL, FLOWTRIEVER, FUROSCIX, DIAMONDBACK CORONARY, V.A.C. VERAFLO, DUPIXENT, MYNX CONTROL.
Industry payments across NE — which companies pay providers there.
